These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 17120736

  • 21. Enhancement of drug-induced apoptosis by antisense oligodeoxynucleotides targeted against Mdm2 and p21WAF1/CIP1.
    Sato N, Mizumoto K, Maehara N, Kusumoto M, Nishio S, Urashima T, Ogawa T, Tanaka M.
    Anticancer Res; 2000; 20(2A):837-42. PubMed ID: 10810363
    [Abstract] [Full Text] [Related]

  • 22. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C, Liu J, Tan C, Yue X, Zhao Y, Peng J, Wang X, Laddha SV, Chan CS, Zheng S, Hu W, Feng Z.
    Oncotarget; 2016 Feb 23; 7(8):8783-96. PubMed ID: 26840028
    [Abstract] [Full Text] [Related]

  • 23. The effect of Tc-99m-labeled MDM2 antisense oligonucleotide on gene expression in human breast cancer MCF-7 cells.
    Zhao C, Fu P, Sheng Y, Li Z.
    J Exp Ther Oncol; 2007 Feb 23; 6(4):297-303. PubMed ID: 18038763
    [Abstract] [Full Text] [Related]

  • 24. Novel MDM2 p53-independent functions identified through RNA silencing technologies.
    Zhang Z, Wang H, Li M, Rayburn E, Agrawal S, Zhang R.
    Ann N Y Acad Sci; 2005 Nov 23; 1058():205-14. PubMed ID: 16394138
    [Abstract] [Full Text] [Related]

  • 25. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J, Yang Q, Li J, Zhou S.
    Angiogenesis; 2014 Jan 23; 17(1):37-50. PubMed ID: 23907365
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development.
    Geatrell JC, Gan PM, Mansergh FC, Kisiswa L, Jarrin M, Williams LA, Evans MJ, Boulton ME, Wride MA.
    Exp Eye Res; 2009 Jun 23; 88(6):1137-51. PubMed ID: 19450442
    [Abstract] [Full Text] [Related]

  • 28. Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.
    Noon AP, Polański R, El-Fert AY, Kalirai H, Shawki H, Campbell F, Dodson A, Eccles RM, Lloyd BH, Sibson DR, Coupland SE, Lake SL, Parsons K, Vlatković N, Boyd MT.
    BJU Int; 2012 Apr 23; 109(8):1250-7. PubMed ID: 21756282
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N, Engel F, Kalayda GV, Mannewitz M, Cinatl J, Rothweiler F, Michaelis M, Saafan H, Ritter CA, Jaehde U, Frötschl R.
    PLoS One; 2017 Apr 23; 12(7):e0181081. PubMed ID: 28746345
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J, Liang R, Bai T, Lin Y, Mai R, Wei M, Ye X, Li L, Wu F.
    J Exp Clin Cancer Res; 2018 Sep 03; 37(1):212. PubMed ID: 30176896
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.
    Zhang Z, Li M, Wang H, Agrawal S, Zhang R.
    Proc Natl Acad Sci U S A; 2003 Sep 30; 100(20):11636-41. PubMed ID: 13130078
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas.
    Nör F, Warner KA, Zhang Z, Acasigua GA, Pearson AT, Kerk SA, Helman JI, Sant'Ana Filho M, Wang S, Nör JE.
    Clin Cancer Res; 2017 Feb 15; 23(4):1036-1048. PubMed ID: 27550999
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
    Park S, Hahm ER, Lee DK, Yang CH.
    J Cell Biochem; 2004 Apr 01; 91(5):973-86. PubMed ID: 15034932
    [Abstract] [Full Text] [Related]

  • 39. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M, Sun Y.
    Anticancer Res; 2003 Apr 01; 23(4):3167-74. PubMed ID: 12926050
    [Abstract] [Full Text] [Related]

  • 40. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
    Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE, Lu X.
    Nat Genet; 2003 Feb 01; 33(2):162-7. PubMed ID: 12524540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.